We can now see sepsis.
Cytovale makes the IntelliSep test, an FDA-cleared in vitro diagnostic that risk-stratifies emergency department patients for sepsis with organ dysfunction by analyzing the biomechanical properties of white blood cells. IntelliSep delivers results in approximately 8 minutes from a small blood sample, enabling faster triage and treatment decisions in a condition where every hour of delay increases mortality by 8%. The test has demonstrated a 42% reduction in mortality and 56% increase in ED discharges in clinical studies.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountOct 2024
Nov 2023
Nov 2019
Create a free account to see which investors have funded this company.
Create Free Account
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
South Korean biotech company and global leader in medical aesthetics, manufacturing botulinum tox...
Global full-service clinical research organization (CRO) and scientific advisory partner for biot...
Global clinical research organization specializing in early-stage clinical trials and bioanalytic...
Provides comprehensive molecular profiling and AI-driven precision oncology services for physicia...
Healthcare company applying technology to drug development by building nimble biotech subsidiarie...
